A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article
Correlations between IOTA index, CA125, HE4, ROMA index | Download Scientific Diagram
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes
He4 and Risk for Ovarian Cancer Algorithm - Dr Lal PathLabs Blog
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-anal | CMAR
Női tumormarker vizsgálatok - Kelen Kórház Budapest
ROMA (Risk of Ovarian Malignancy Algorithm) | PPT
Mit jelent a HE4 érték a laborleletben? | Dr. Girhiny Tamás
Tumor marker jajnika (CA 125, HE4, ROMA index) - kompletna analiza u Poliklinici na Zvezdari!
ROMA Index Laboratory research Synevo
Tumormarker vizsgálatok az F MEDICAL Magánklinikán
Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
Tumor marker jajnika (CA 125, HE4, ROMA index) - kompletna analiza za samo 2760 rsd - HitDoktor.com grupna kupovina
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
Human Epididymis Protein 4 - an overview | ScienceDirect Topics
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
Ovarian Cancer | myADLM.org
Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Tumor marker levels and risk of ovarian malignancy algorithm (ROMA)... | Download Scientific Diagram
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
